Now I have the full picture. Let me write the post.

—

“`

The Week in the Indices

The Nasdaq 100 fell 4.50% to 706.5, its worst week since the early-June semiconductor rout, after a New York Times report that OpenAI is weighing a delay of its IPO until 2027 rattled every corner of the AI trade. The S&P 500 dropped 2.38% to 729, pulled lower by Apple and Microsoft — both top-weighted components — shedding over 6% and 3% respectively.

But this was a rotation, not a liquidation. The Russell 2000 climbed 1.43% to 299.8, catching the money leaving mega-cap tech, while the Dow eked out a 0.43% gain to 517.8 — its healthcare, financial, and industrial tilt absorbed exactly the capital that tech repelled. The VIX rose 12.26% to 18.41, elevated enough to price in continued chop but well below the 20 threshold that would signal outright fear. The options market is cautious, not panicked.

Sector Winners & Losers

Healthcare (XLV) dominated the week, surging 7.80% — the kind of weekly move that turns heads even in a defensive sector. Amgen’s MariTide Phase 2 extension data showed patients sustaining weight loss on monthly or quarterly dosing, pulling the entire pharma complex higher alongside names like UnitedHealth, Merck, and Johnson & Johnson. Piper Sandler and Morgan Stanley both flagged AMGN’s pipeline strength, and the bid spread across the sector.

Energy (XLE, +0.85%), Financials (XLF, +0.35%), and Industrials (XLI, +0.41%) all posted modest gains — the classic “everything except tech” rotation pattern. Technology (XLK) sat at the bottom, down 5.28%, with Consumer Discretionary (XLY, -2.19%) dragged lower by Tesla’s exposure to the same AI valuation compression. Materials (XLB) was flat at -0.03%. The sector tape reads as a defensive broadening, not a risk-off flush.

Rates, Commodities & the Dollar

The 10-year Treasury yield edged down to 4.451% (-0.27%) and the 30-year fell to 4.901% (-1.01%) as the bond market absorbed a mild flight-to-quality bid. Lower yields supported the rate-sensitive Russell 2000 but weren’t dramatic enough to signal recession pricing.

Commodities told a harder story. WTI crude dropped 9.62% to $69.23 — a sharp move that overwhelmed any geopolitical risk premium from the U.S.-Iran situation, pointing instead to softening global demand expectations. Silver collapsed 10.62% to $59.22, gold fell 3.44% to $4,079, and copper shed 3.66% to $6.141. The industrial metals selloff suggests the growth-proxy trade is fading. The DXY firmed 0.51% to 101.4, with EUR/USD down 0.60% to 1.139 — a modest dollar bid consistent with risk-off positioning without panic repatriation flows.

What Drove the Week

Three catalysts set the tone. First, the New York Times reported Thursday that OpenAI is considering pushing its IPO to 2027 after watching SpaceX give back nearly all of its post-IPO gains. The report exposed how much of the AI trade was priced on liquidity events rather than fundamentals — SoftBank fell 12% in Tokyo, and the SOX index approached correction territory. Second, Amgen’s obesity drug data gave institutional buyers a reason to rotate into healthcare with conviction, not just hide. Third, the U.S. confirmed retaliatory strikes on Iran, but crude still fell hard on the week — the market is pricing demand weakness above geopolitical supply risk, a bearish tell for the energy complex despite XLE’s modest weekly gain.

Week Ahead

The bias entering next week is defensive rotation with a floor — the S&P is still up roughly 10% year-to-date and parked near record territory, so this reads as a pullback inside an uptrend. Watch the Nasdaq 100 at 700: a clean break below that level would extend the unwind into a second week, while a hold and bounce would confirm the rotation thesis over something more structural. Jobs data drops next week and will be the single biggest catalyst — a soft print gives the Fed room to stay patient, while a hot number re-tightens the rate narrative and pressures growth stocks further. At Luna3, we’ll be tracking whether healthcare holds its bid or gives back gains once the Amgen catalyst fades.

Read next: Market Pulse · VIX Term Structure · What Is a Bond?